Usama Gergis joined The Sidney Kimmel Cancer Center–Jefferson Health as director of the Bone Marrow Transplant and Immune Cellular Therapy Program and professor in the Department of Medical Oncology, Division of Hematological Malignancies.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
